Disclosure 0001193125-26-382277-2

SEC FORM 4

$2,086,500.00

Axsome Therapeutics, Inc. (AXSM)

Sale of 10,000 shares at $208.65 per share.

Reporting Person Jacobson Mark L. · Officer Title Chief Operating Officer · Transaction Code S

Traded Sep 3, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001193125-26-382277 · filed 2026-09-03 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Axsome Therapeutics, Inc. (AXSM)." Disclosed 2026-09-03. https://desqlong.com/cards/0001193125-26-382277-2 (retrieved 2026-09-26).